Select therapeutic use:
Indications for FIRAZYR:
Treatment of acute attacks of hereditary angioedema (HAE).
≥18yrs: 30mg SC in abdominal area; may give additional doses at intervals of at least 6 hours if response inadequate or symptoms recur. Max 3 doses/24hrs.
<18yrs: not recommended.
Advise patients to seek medical attention after treating laryngeal attack given the potential for airway obstruction. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.
May attenuate the antihypertensive effect of ACE inhibitors.
Bradykinin B2 receptor antagonist.
Inj site reactions, pyrexia, transaminase increase, dizziness, rash.
Single-use prefilled syringe (3mL)—1, 3